CMS' 2025 Final Rule included an increased payment for Intrinsic Therapeutics' Barricaid device, according to a Nov. 12 news release.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback